Abstract
Accurate diagnosis of mild cognitive impairment (MCI) before conversion to Alzheimer's disease (AD) is invaluable for patient treatment. Many works showed that MCI and AD affect functional and structural connections between brain regions as well as the shape of cortical regions. However, 'shape connections' between brain regions are rarely investigated -e.g., how morphological attributes such as cortical thickness and sulcal depth of a specific brain region change in relation to morphological attributes in other regions. To fill this gap, we unprecedentedly design morphological brain multiplexes for late MCI/AD classification. Specifically, we use structural T1-w MRI to define morphological brain networks, each quantifying similarity in morphology between different cortical regions for a specific cortical attribute. Then, we define a brain multiplex where each intra-layer represents the morphological connectivity network of a specific cortical attribute, and each inter-layer encodes the similarity between two consecutive intra-layers. A significant performance gain is achieved when using the multiplex architecture in comparison to other conventional network analysis architectures. We also leverage this architecture to discover morphological connectional biomarkers fingerprinting the difference between late MCI and AD stages, which included the right entorhinal cortex and right caudal middle frontal gyrus.
Original language | English (US) |
---|---|
Article number | 4103 |
Journal | Scientific reports |
Volume | 8 |
Issue number | 1 |
DOIs | |
State | Published - Dec 1 2018 |
ASJC Scopus subject areas
- General
Fingerprint
Dive into the research topics of 'Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Scientific reports, Vol. 8, No. 1, 4103, 01.12.2018.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states
AU - Mahjoub, Ines
AU - Mahjoub, Mohamed Ali
AU - Rekik, Islem
AU - Weiner, Michael
AU - Aisen, Paul
AU - Petersen, Ronald
AU - Jack, Cliford
AU - Jagust, William
AU - Trojanowki, John
AU - Toga, Arthur
AU - Beckett, Laurel
AU - Green, Robert
AU - Saykin, Andrew
AU - Morris, John
AU - Shaw, Leslie
AU - Kaye, Jefrey
AU - Quinn, Joseph
AU - Silbert, Lisa
AU - Lind, Betty
AU - Carter, Raina
AU - Dolen, Sara
AU - Schneider, Lon
AU - Pawluczyk, Sonia
AU - Beccera, Mauricio
AU - Teodoro, Liberty
AU - Spann, Bryan
AU - Brewer, James
AU - Vanderswag, Helen
AU - Fleisher, Adam
AU - Heidebrink, Judith
AU - Lord, Joanne
AU - Mason, Sara
AU - Albers, Colleen
AU - Knopman, David
AU - Johnson, Kris
AU - Doody, Rachelle
AU - Villanueva-Meyer, Javier
AU - Chowdhury, Munir
AU - Rountree, Susan
AU - Dang, Mimi
AU - Stern, Yaakov
AU - Honig, Lawrence
AU - Bell, Karen
AU - Ances, Beau
AU - Carroll, Maria
AU - Creech, Mary
AU - Franklin, Erin
AU - Mintun, Mark
AU - Schneider, Stacy
AU - Oliver, Angela
AU - Marson, Daniel
AU - Grifth, Randall
AU - Clark, David
AU - Geldmacher, David
AU - Brockington, John
AU - Roberson, Erik
AU - Natelson Love, Marissa
AU - Grossman, Hillel
AU - Mitsis, Efe
AU - Shah, Raj
AU - Detoledo-Morrell, Leyla
AU - Duara, Ranjan
AU - Varon, Daniel
AU - Greig, Maria
AU - Roberts, Peggy
AU - Albert, Marilyn
AU - Onyike, Chiadi
AU - D'Agostino, Daniel
AU - Kielb, Stephanie
AU - Galvin, James
AU - Cerbone, Brittany
AU - Michel, Christina
AU - Pogorelec, Dana
AU - Rusinek, Henry
AU - De Leon, Mony
AU - Glodzik, Lidia
AU - De Santi, Susan
AU - Doraiswamy, P.
AU - Petrella, Jefrey
AU - Borges-Neto, Salvador
AU - Wong, Terence
AU - Coleman, Edward
AU - Smith, Charles
AU - Jicha, Greg
AU - Hardy, Peter
AU - Sinha, Partha
AU - Oates, Elizabeth
AU - Conrad, Gary
AU - Porsteinsson, Anton
AU - Goldstein, Bonnie
AU - Martin, Kim
AU - Makino, Kelly
AU - Ismail, M.
AU - Brand, Connie
AU - Mulnard, Ruth
AU - Thai, Gaby
AU - Mc-Adams-Ortiz, Catherine
AU - Womack, Kyle
AU - Mathews, Dana
AU - Quiceno, Mary
AU - Levey, Allan
AU - Lah, James
AU - Cellar, Janet
AU - Burns, Jefrey
AU - Swerdlow, Russell
AU - Brooks, William
AU - Apostolova, Liana
AU - Tingus, Kathleen
AU - Woo, Ellen
AU - Silverman, Daniel
AU - Lu, Po
AU - Bartzokis, George
AU - Graf-Radford, Neill
AU - Parftt, Francine
AU - Kendall, Tracy
AU - Johnson, Heather
AU - Farlow, Martin
AU - Hake, Ann Marie
AU - Matthews, Brandy
AU - Brosch, Jared
AU - Herring, Scott
AU - Hunt, Cynthia
AU - Dyck, Christopher
AU - Carson, Richard
AU - MacAvoy, Martha
AU - Varma, Pradeep
AU - Chertkow, Howard
AU - Bergman, Howard
AU - Hosein, Chris
AU - Black, Sandra
AU - Stefanovic, Bojana
AU - Caldwell, Curtis
AU - Robin Hsiung, Ging Yuek
AU - Feldman, Howard
AU - Mudge, Benita
AU - Assaly, Michele
AU - Finger, Elizabeth
AU - Pasternack, Stephen
AU - Rachisky, Irina
AU - Trost, Dick
AU - Kertesz, Andrew
AU - Bernick, Charles
AU - Munic, Donna
AU - Mesulam, Marek Marsel
AU - Lipowski, Kristine
AU - Weintraub, Sandra
AU - Bonakdarpour, Borna
AU - Kerwin, Diana
AU - Wu, Chuang Kuo
AU - Johnson, Nancy
AU - Sadowsky, Carl
AU - Villena, Teresa
AU - Turner, Raymond Scott
AU - Johnson, Kathleen
AU - Reynolds, Brigid
AU - Sperling, Reisa
AU - Johnson, Keith
AU - Marshall, Gad
AU - Yesavage, Jerome
AU - Taylor, Joy
AU - Lane, Barton
AU - Rosen, Allyson
AU - Tinklenberg, Jared
AU - Sabbagh, Marwan
AU - Belden, Christine
AU - Jacobson, Sandra
AU - Sirrel, Sherye
AU - Kowall, Neil
AU - Killiany, Ronald
AU - Budson, Andrew
AU - Norbash, Alexander
AU - Johnson, Patricia Lynn
AU - Obisesan, Thomas
AU - Wolday, Saba
AU - Allard, Joanne
AU - Lerner, Alan
AU - Ogrocki, Paula
AU - Tatsuoka, Curtis
AU - Fatica, Parianne
AU - Fletcher, Evan
AU - Maillard, Pauline
AU - Olichney, John
AU - Decarli, Charles
AU - Carmichael, Owen
AU - Kittur, Smita
AU - Borrie, Michael
AU - Lee, T. Y.
AU - Bartha, Rob
AU - Johnson, Sterling
AU - Asthana, Sanjay
AU - Carlsson, Cynthia
AU - Potkin, Steven
AU - Preda, Adrian
AU - Nguyen, Dana
AU - Tariot, Pierre
AU - Burke, Anna
AU - Trncic, Nadira
AU - Reeder, Stephanie
AU - Bates, Vernice
AU - Capote, Horacio
AU - Rainka, Michelle
AU - Scharre, Douglas
AU - Kataki, Maria
AU - Adeli, Anahita
AU - Zimmerman, Earl
AU - Celmins, Dzintra
AU - Brown, Alice
AU - Pearlson, Godfrey
AU - Blank, Karen
AU - Anderson, Karen
AU - Flashman, Laura
AU - Seltzer, Marc
AU - Hynes, Mary
AU - Santulli, Robert
AU - Sink, Kaycee
AU - Gordineer, Leslie
AU - Williamson, Jef
AU - Garg, Pradeep
AU - Watkins, Franklin
AU - Ott, Brian
AU - Querfurth, Henry
AU - Tremont, Geofrey
AU - Salloway, Stephen
AU - Malloy, Paul
AU - Correia, Stephen
AU - Rosen, Howard
AU - Miller, Bruce
AU - Perry, David
AU - Mintzer, Jacobo
AU - Spicer, Kenneth
AU - Bachman, David
AU - Pomara, Nunzio
AU - Hernando, Raymundo
AU - Sarrael, Antero
AU - Relkin, Norman
AU - Chaing, Gloria
AU - Lin, Michael
AU - Ravdin, Lisa
AU - Smith, Amanda
AU - Raj, Balebail Ashok
AU - Fargher, Kristin
N1 - Funding Information: This work was supported in part by the University of Dundee Research Fund. Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc. edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. Publisher Copyright: © 2018 The Author(s).
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Accurate diagnosis of mild cognitive impairment (MCI) before conversion to Alzheimer's disease (AD) is invaluable for patient treatment. Many works showed that MCI and AD affect functional and structural connections between brain regions as well as the shape of cortical regions. However, 'shape connections' between brain regions are rarely investigated -e.g., how morphological attributes such as cortical thickness and sulcal depth of a specific brain region change in relation to morphological attributes in other regions. To fill this gap, we unprecedentedly design morphological brain multiplexes for late MCI/AD classification. Specifically, we use structural T1-w MRI to define morphological brain networks, each quantifying similarity in morphology between different cortical regions for a specific cortical attribute. Then, we define a brain multiplex where each intra-layer represents the morphological connectivity network of a specific cortical attribute, and each inter-layer encodes the similarity between two consecutive intra-layers. A significant performance gain is achieved when using the multiplex architecture in comparison to other conventional network analysis architectures. We also leverage this architecture to discover morphological connectional biomarkers fingerprinting the difference between late MCI and AD stages, which included the right entorhinal cortex and right caudal middle frontal gyrus.
AB - Accurate diagnosis of mild cognitive impairment (MCI) before conversion to Alzheimer's disease (AD) is invaluable for patient treatment. Many works showed that MCI and AD affect functional and structural connections between brain regions as well as the shape of cortical regions. However, 'shape connections' between brain regions are rarely investigated -e.g., how morphological attributes such as cortical thickness and sulcal depth of a specific brain region change in relation to morphological attributes in other regions. To fill this gap, we unprecedentedly design morphological brain multiplexes for late MCI/AD classification. Specifically, we use structural T1-w MRI to define morphological brain networks, each quantifying similarity in morphology between different cortical regions for a specific cortical attribute. Then, we define a brain multiplex where each intra-layer represents the morphological connectivity network of a specific cortical attribute, and each inter-layer encodes the similarity between two consecutive intra-layers. A significant performance gain is achieved when using the multiplex architecture in comparison to other conventional network analysis architectures. We also leverage this architecture to discover morphological connectional biomarkers fingerprinting the difference between late MCI and AD stages, which included the right entorhinal cortex and right caudal middle frontal gyrus.
UR - http://www.scopus.com/inward/record.url?scp=85048280147&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048280147&partnerID=8YFLogxK
U2 - 10.1038/s41598-018-21568-7
DO - 10.1038/s41598-018-21568-7
M3 - Article
C2 - 29515158
AN - SCOPUS:85048280147
SN - 2045-2322
VL - 8
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 4103
ER -